BioStem Technologies Inc (BSEM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BioStem Technologies Inc (BSEM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9362
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioStem Technologies Inc. (BioStem Technologies), formerly Caribbean International Holdings Inc., is a life sciences company that discovers, develops and manufactures pharmaceuticals and regenerative medicines. Through its subsidiaries, the company discovers, develops, produces and commercializes stem cell and wellness products. It provides regenerative biologics for the treatment of muscular, joint, neurodegenerative and autoimmune diseases. BioStem Technologies offers products and services such as clinical stem cell therapy, stem cell R&D, laboratory services, and pharmaceutical reformulation, development and sales, besides APIs. It also provides product development services such as stability studies, process validations and cleaning validations, formulation development pilot batches and NDA and ANDA submission filings. BioStem Technologies is headquartered in Pompano Beach, Florida, the US.

BioStem Technologies Inc (BSEM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioStem Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Nesvik Pharma Acquires New Drug Compounds from CCM Pharma 10
Venture Financing 11
BioStem Technologies Raises Funds through Venture Financing 11
Partnerships 12
BioStem Technologies to Enter into Agreement with CCM Pharma Solutions 12
Equity Offering 13
BioStem Technologies to Raise USD15 Million in Private Placement 13
Acquisition 14
BioStem Technologies to Acquire GIINT 14
BioStem Technologies Inc – Key Competitors 15
BioStem Technologies Inc – Key Employees 16
BioStem Technologies Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Aug 09, 2018: Biostem Technologies launches new subsidiary to engage in the processing and supply of regenerative tissue products 18
Corporate Communications 19
Apr 04, 2018: BioStem Technologies Enters Into Consulting and Advisory Agreement with Dr. Irmgard Huber 19
Feb 08, 2018: BioStem Technologies Adds Chief Revenue Officer to Executive Team 20
Jan 24, 2018: BioStem Technologies Appoints Jennie Sandqvist As New Board Member 21
Dec 01, 2017: BioStem Technologies Announces the Addition of University of Miami Professor Brant D. Watson, Ph.D., to the Company’s Scientific Advisory Board 22
Legal and Regulatory 23
Jun 18, 2018: BioStem Technologies Announces Issuance of Drug Enforcement Administration Registration for Qualified Pharma Ingredients 23
Nov 01, 2017: BioStem Technologies Files “Issuer Company-Related Action Notification” with the Financial Industry Regulatory Authority, Requesting Name and Symbol Change to BioBlue Technologies 24
Clinical Trials 25
Dec 11, 2017: BioStem Technologies Announces a Pre-Clinical Study of BSEM17-115 at University of Miami 25
Other Significant Developments 26
Mar 27, 2017: BioStem Technologies Announces Issuance of Prescription Drug Repackager Permit for Qualified Pharma Ingredients 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioStem Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioStem Technologies Inc, Deals By Therapy Area, 2012 to YTD 2018 8
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nesvik Pharma Acquires New Drug Compounds from CCM Pharma 10
BioStem Technologies Raises Funds through Venture Financing 11
BioStem Technologies to Enter into Agreement with CCM Pharma Solutions 12
BioStem Technologies to Raise USD15 Million in Private Placement 13
BioStem Technologies to Acquire GIINT 14
BioStem Technologies Inc, Key Competitors 15
BioStem Technologies Inc, Key Employees 16
BioStem Technologies Inc, Subsidiaries 17

List of Figures
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioStem Technologies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[BioStem Technologies Inc (BSEM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • JPMorgan Chase & Co (JPM):企業の財務・戦略的SWOT分析
    JPMorgan Chase & Co (JPM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Carl Zeiss AG:企業の戦略的SWOT分析
    Carl Zeiss AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Delegat’s Group Limited:企業の戦略・SWOT・財務情報
    Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report Summary Delegat's Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Galliford Try Holdings Plc (GFRD):企業の財務・戦略的SWOT分析
    Galliford Try Holdings Plc (GFRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Exact Holding N.V.:企業の戦略的SWOT分析
    Exact Holding N.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Nostra Terra Oil and Gas Company plc (NTOG):企業の財務・戦略的SWOT分析
    Summary Nostra Terra Oil and Gas Company Plc (NTOG) is an oil and gas company. The company explores, produces, and develops oil and gas properties across the US. It holds interest in operating and non-operating working interests in its projects located in Texas, New Mexico, Wyoming, Kansas, Colorado …
  • Xinjiang Xinxin Mining Industry Co., Ltd:企業の戦略・SWOT・財務情報
    Xinjiang Xinxin Mining Industry Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Xinjiang Xinxin Mining Industry Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Mizuho Bank Ltd:企業のM&A・事業提携・投資動向
    Mizuho Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mizuho Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Auswide Bank Ltd (ABA):企業の財務・戦略的SWOT分析
    Auswide Bank Ltd (ABA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Tecpetrol SA:企業の戦略的SWOT分析
    Tecpetrol SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • ReShape Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary ReShape Medical Inc (ReShape Medical), a subsidiary of EnteroMedics Inc is a medical device company that offers weight loss solutions. The company provides dual intragastric balloon for weight loss. Its product comprises of ReShape Duo, a non surgical dual-intragastric balloon used in the tr …
  • Turboatom (TATM):企業の財務・戦略的SWOT分析
    Turboatom (TATM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Net One Systems Co Ltd (7518):企業の財務・戦略的SWOT分析
    Net One Systems Co Ltd (7518) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Lonmin Plc:企業の戦略・SWOT・財務情報
    Lonmin Plc - Strategy, SWOT and Corporate Finance Report Summary Lonmin Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Indena SpA:企業の戦略的SWOT分析
    Indena SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Qioptiq Group:企業の戦略的SWOT分析
    Qioptiq Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • GLG Life Tech Corp (GLG):企業の財務・戦略的SWOT分析
    GLG Life Tech Corp (GLG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sarawak Energy Bhd:企業の戦略的SWOT分析
    Sarawak Energy Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • EyePoint Pharmaceuticals Inc (PSDV):医療機器:M&Aディール及び事業提携情報
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert …
  • Dome Investments Public Company Limited:企業の戦略・SWOT・財務情報
    Dome Investments Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Dome Investments Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆